Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Y Hsia

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Alimentary Pharmacology & Therapeutics|July 24, 2012
A prognostic model for patients with hepatocellular carcinoma within the Milan criteria undergoing non-transplant therapies, based on 1106 patientsY-H Lee, C-Y Hsu, C-Y Hsia, et al.
Zhonghua Yi Xue Za Zhi = Chinese Medical Journal; Free China Ed|April 2, 2002
A progressive growing inflammatory pseudotumor of the liverC C Lu, C C Chen, C Y Hsia, et al.
Surgery|June 7, 2000
Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinomaT J Tsai, G Y Chau, W Y Lui, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|July 2, 1999
Evaluation of a simplified staging system for prognosis of hepatocellular carcinomaW Y Lui, S T Chiu, J H Chiu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|October 3, 2001
Clinicopathologic and prognostic differences between patients with hepatitis B- and C-related resectable hepatocellular carcinomaT H Chen, L M Tseng, G Y Chau, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 5, 2006
Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinomaC-Y Hsia, T-I Huo, S-Y Chiang, et al.
Annals of Surgery|April 5, 2000
Serum interleukin-10 but not interleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinomaG Y Chau, C W Wu, W Y Lui, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 15, 2008
The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective surveyT-I Huo, H-C Lin, C-Y Hsia, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 16, 2015
Incidence and Risk Factors for Tuberculosis After Liver Transplantation in an Endemic Area: A Nationwide Population-Based Matched Cohort StudyC-Y Chen, C-J Liu, J-Y Feng, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Alimentary Pharmacology & Therapeutics|July 24, 2012
A prognostic model for patients with hepatocellular carcinoma within the Milan criteria undergoing non-transplant therapies, based on 1106 patientsY-H Lee, C-Y Hsu, C-Y Hsia, et al.
Zhonghua Yi Xue Za Zhi = Chinese Medical Journal; Free China Ed|April 2, 2002
A progressive growing inflammatory pseudotumor of the liverC C Lu, C C Chen, C Y Hsia, et al.
Surgery|June 7, 2000
Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinomaT J Tsai, G Y Chau, W Y Lui, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|July 2, 1999
Evaluation of a simplified staging system for prognosis of hepatocellular carcinomaW Y Lui, S T Chiu, J H Chiu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|October 3, 2001
Clinicopathologic and prognostic differences between patients with hepatitis B- and C-related resectable hepatocellular carcinomaT H Chen, L M Tseng, G Y Chau, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 5, 2006
Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinomaC-Y Hsia, T-I Huo, S-Y Chiang, et al.
Annals of Surgery|April 5, 2000
Serum interleukin-10 but not interleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinomaG Y Chau, C W Wu, W Y Lui, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 15, 2008
The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective surveyT-I Huo, H-C Lin, C-Y Hsia, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 16, 2015
Incidence and Risk Factors for Tuberculosis After Liver Transplantation in an Endemic Area: A Nationwide Population-Based Matched Cohort StudyC-Y Chen, C-J Liu, J-Y Feng, et al.
Pageof 2